Clinical Trial Update: Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating Dinalbuphine Ester (Naldebain) for postoperative pain management after cesarean section is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain
• Postsurgical Pain

Drugs mentioned

• Naldebain (dinalbuphine ester)

Snippet

Sponsor: Dalin Tzu Chi General Hospital | Conditions: Postsurgical Pain, Cesarean Section | Phase 2, Phase 3 | Status: RECRUITING